Agios Pharmaceuticals | AGIO - Zapasy





Zapasy Zmiana Data
AbbVie USD 4.95B 13M 2025-12
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Astellas Pharma JPY 297.26B 9.92B 2025-03
AstraZeneca USD 6.56B 36M 2025-12
Bayer EUR 12.33B 221M 2025-09
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.77B 11M 2025-12
GlaxoSmithKline GBP 5.92B 194M 2025-12
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.27B 152M 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12